Safe Comprehensive Therapy to Prevent Complications in Children with Catarrhal Symptoms Associated with Acute Viral Respiratory Infections: Series of Clinical Cases
|
|
Author:
|
KIR'JANOVA V.V, KORZHENEVSKAJA T.B, AKSENOVA N.N
|
Abstract:
|
Introduction: Ethiopathogenetic medicinal products are included into the active range of therapeutic
instruments in the treatment of acute bronchitis in children with acute respiratory viral infection (ARVI).
Although using the medicinal products of this group should be strictly regulated and provide a differentiated
individual approach with an emphasis to the use of immunocorrective preparations. This article summarizes a
number of Clinical Cases of children with catarrhal symptoms of the lower respiratory tract associated with
ARVI, received pharmaceutical products and new physiotherapeutic treatment approaches.
Results: The new treatment method has demonstrated a good effect and high safety profile in acute
bronchitis induced by virus infections, including adenovirus, rhinosyncytial (RS) virus, parainfluenza virus with
underlying persistence of Epstein Barr virus (EBV), cytomegalovirus (CMV), S.aureus, S.pneumoniae and other
microorganisms in the lower respiratory tract. As a result of therapy the ear nose throat (ENT) and
pulmonary catarrhal symptoms were cured in sub- and decompensated dysbiosis of respiratory tract mucus
membranes with underlying serum neutropenia, irrespective of etiology and complete blood count parameters.
Conclusion: We noted that there were no lower respiratory tract bacterial complications in children with
lower respiratory tract catarrhal symptoms associated with ARVI who used initial inhalation administration of
the medicinal product based on Interferon Gamma in combination with subsequent narrow-band optical
radiation with a wavelength 470 nm (blue light); no delayed or recurrent course of the disease was registered.
The comprehensive therapy showed safety and efficacy in patients aged from 7 to 17 years.
|
Keyword:
|
ARVI, lower respiratory tract catarrhal symptoms, children, Interferon Gamma, inhalations, narrow-band optical radiation with a wavelength 470 nm (blue light)
|
EOI:
|
-
|
DOI:
|
https://doi.org/10.31838/ijpr/2021.13.02.284
|
Download:
|
Request For Article
|
|
|